275 related articles for article (PubMed ID: 11593421)
1. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth.
Pierantoni GM; Fedele M; Pentimalli F; Benvenuto G; Pero R; Viglietto G; Santoro M; Chiariotti L; Fusco A
Oncogene; 2001 Sep; 20(43):6132-41. PubMed ID: 11593421
[TBL] [Abstract][Full Text] [Related]
2. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
3. The serine/threonine kinase HIPK2 interacts with TRADD, but not with CD95 or TNF-R1 in 293T cells.
Li X; Wang Y; Debatin KM; Hug H
Biochem Biophys Res Commun; 2000 Oct; 277(2):513-7. PubMed ID: 11032752
[TBL] [Abstract][Full Text] [Related]
4. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
Lee SW; Kim EJ; Um SJ
Biochem Biophys Res Commun; 2006 Jan; 339(4):1056-62. PubMed ID: 16343438
[TBL] [Abstract][Full Text] [Related]
5. The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4.
Yamada D; Pérez-Torrado R; Filion G; Caly M; Jammart B; Devignot V; Sasai N; Ravassard P; Mallet J; Sastre-Garau X; Schmitz ML; Defossez PA
Oncogene; 2009 Jul; 28(27):2535-44. PubMed ID: 19448668
[TBL] [Abstract][Full Text] [Related]
6. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status.
Giannini G; Kim CJ; Di Marcotullio L; Manfioletti G; Cardinali B; Cerignoli F; Ristori E; Zani M; Frati L; Screpanti I; Guilino A
Br J Cancer; 2000 Dec; 83(11):1503-9. PubMed ID: 11076660
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad-mesonephros hematopoiesis.
Ohtsu N; Nobuhisa I; Mochita M; Taga T
Exp Cell Res; 2007 Jan; 313(1):88-97. PubMed ID: 17064687
[TBL] [Abstract][Full Text] [Related]
8. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival.
Wiggins AK; Wei G; Doxakis E; Wong C; Tang AA; Zang K; Luo EJ; Neve RL; Reichardt LF; Huang EJ
J Cell Biol; 2004 Oct; 167(2):257-67. PubMed ID: 15492043
[TBL] [Abstract][Full Text] [Related]
9. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
Rui Y; Xu Z; Lin S; Li Q; Rui H; Luo W; Zhou HM; Cheung PY; Wu Z; Ye Z; Li P; Han J; Lin SC
EMBO J; 2004 Nov; 23(23):4583-94. PubMed ID: 15526030
[TBL] [Abstract][Full Text] [Related]
10. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors.
Tallini G; Dal Cin P
Adv Anat Pathol; 1999 Sep; 6(5):237-46. PubMed ID: 10472377
[TBL] [Abstract][Full Text] [Related]
11. Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction.
Dai F; Yu L; He H; Chen Y; Yu J; Yang Y; Xu Y; Ling W; Zhao S
Biochem Biophys Res Commun; 2002 May; 293(4):1191-6. PubMed ID: 12054501
[TBL] [Abstract][Full Text] [Related]
12. Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis.
Tkachenko A; Ashar HR; Meloni AM; Sandberg AA; Chada KK
Cancer Res; 1997 Jun; 57(11):2276-80. PubMed ID: 9187132
[TBL] [Abstract][Full Text] [Related]
13. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.
Scala S; Portella G; Fedele M; Chiappetta G; Fusco A
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4256-61. PubMed ID: 10759549
[TBL] [Abstract][Full Text] [Related]
15. Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins.
Fedele M; Bandiera A; Chiappetta G; Battista S; Viglietto G; Manfioletti G; Casamassimi A; Santoro M; Giancotti V; Fusco A
Cancer Res; 1996 Apr; 56(8):1896-901. PubMed ID: 8620511
[TBL] [Abstract][Full Text] [Related]
16. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
18. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
Gresko E; Möller A; Roscic A; Schmitz ML
Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
[TBL] [Abstract][Full Text] [Related]
19. Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation.
Harada J; Kokura K; Kanei-Ishii C; Nomura T; Khan MM; Kim Y; Ishii S
J Biol Chem; 2003 Oct; 278(40):38998-9005. PubMed ID: 12874272
[TBL] [Abstract][Full Text] [Related]
20. A proline-rich domain in the gamma subunit of phosphodiesterase 6 mediates interaction with SH3-containing proteins.
Morin F; Vannier B; Houdart F; Regnacq M; Berges T; Voisin P
Mol Vis; 2003 Sep; 9():449-59. PubMed ID: 14502124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
